Bankrupt opioid manufacturer Purdue and the Sackler family have agreed to a $7.4 billion settlement to resolve opioid claims ...

Purdue Pharma has filed a new bankruptcy plan as part of a $7.4 billion settlement to resolve thousands of lawsuits over the ...

Purdue Pharma has filed a new bankruptcy plan that will distribute more than $7.4 billion to compensate opioid epidemic ...

(Billable Hours is Reuters' weekly report on lawyers and money. Please send tips or suggestions to ...

Members of the Sackler family who own the OxyContin maker Purdue Pharma would hand over the company and up to $7 billion in ...

Purdue Pharma submitted a new bankruptcy plan Tuesday, which will give its creditors more than $7.4 billion in cash—including up to $7 billion in payments from the billionaire Sackler family ...

Purdue Pharma has filed a new reorganization plan that aims to deliver more than $7.4 billion in cash to creditors, subject to certain reserves, to compensate victims and abate the opioid crisis.

Purdue Pharma LP has filed a new Chapter 11 plan with the US Bankruptcy Court for the Southern District of New York, pledging ...

Purdue Pharma filed a new bankruptcy plan on Tuesday, a major step toward finalizing a proposed opioid settlement of at least $7.4 billion after a setback in the U.S. Supreme Court last year.

Purdue Pharma has filed a new bankruptcy plan that details how the funds will be allocated and the proportion paid by its owners, nearly two months after agreeing to a $7.4bn opioid settlement.

Sacklers to contribute approximately $6.5 – $7 billion, $1 billion more than under previous Plan $2.4 billion of cash expected to be distributed on the effective date Company assets will be ...

The bankrupt drugmaker and OxyContin manufacturer will be dissolved and its assets transferred to a new company.